Also trades as: CDT (NASDAQ) · $vol 0M
CDTTW NASDAQ
CDT Equity Inc.
1W: +14.8%
1M: +112.1%
3M: +62.8%
YTD: +129.5%
1Y: +12.0%
$0.01
+0.00 (+44.33%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0119-0.0144
Volume2,783
Avg Volume32,919
Beta1.57
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAndrew Regan
Employees6
SectorHealthcare
IndustryBiotechnology
IPO Date2022-03-28
Websiteconduitpharma.com
4581 Tamiami Trail North
Naples, FL 34103
US
Naples, FL 34103
US
646 491 9132
About CDT Equity Inc.
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Olsen Ulrik K | 0 | — | 2026-04-27 | |
| Regan Andrew | A-Award | 147,401 | — | 2026-03-24 |
| Regan Andrew | C-Conversion | 147,401 | $0.00 | 2026-03-24 |
| Taylor Mark Andrew | J-Other | 51,420,358 | — | 2026-03-17 |
| Taylor Mark Andrew | J-Other | 51,161,318 | — | 2026-03-17 |